LIPO — what changed in the latest 10-Q
A section-by-section comparison of LIPO's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2025-11-14 vs the prior 10-Q · 2025-08-14
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +24 | −23 | ~12 | 80 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Text added/removed | 0 | 0 | ~4 | 10 |
| Other information | Text added/removed | 0 | 0 | ~1 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2025-11-14
● our ability to raise additional capital will be more difficult as a company whose common stock is traded on the OTC markets;
● if we are unable to raise additional capital, we may be forced to curtail or cease operations or file for bankruptcy protection or pursue a dissolution and liquidation of all of our remaining assets;
On October 3, 2025, Dr. Michael Chancellor notified the Company of his intention to retire from his positions as the Company’s Chief Medical Officer and a member of the Company’s Board of Directors, effective December 4, 2025.
Comparison of the Three Months Ended September 30, 2025 and 2024
The following table summarizes our results of operations for the three months ended September 30, 2025 and 2024 (in thousands):
Text removed vs the prior filing · source: 10-Q · 2025-08-14
Dr. Jonathan Kaufman, our Chief Executive Officer, and Dr. Michael Chancellor, our Chief Medical Officer, co-founded the Company in 2005. On December 22, 2022, we completed our initial public offering, receiving approximately $5.0 million in aggregate net proceeds. Our principal executive offices ar…
On April 4, 2025, we entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC (“Wainwright”) to sell shares of Common Stock having an aggregate offering price of up to $2,641,881, from time to time, through an “at the market offering” program under which Wainwright will act a…
On April 8, 2025, we filed a Certificate of Amendment (the “Series C Certificate of Amendment”) to the Certificate of Designation of Preferences, Rights and Limitations of Series C Voting Convertible Preferred Stock (the “Series C Certificate of Designation”) with the Secretary of State of the State…
As previously disclosed, on May 12, 2025, we received a written notification (the “May Letter”) from the Listing Qualifications Department (the “Staff”) notifying us that the Staff determined that we failed to comply with Nasdaq’s shareholder approval and voting rights requirements in connection wit…
On June 20, 2025, we received a letter (the “June Letter”) from the Panel indicating that the Panel had determined to delist the Common Stock from the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5100, which permits Nasdaq to use its discretionary authority for public interest concerns, due…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice